text:
Putting someone down is no way to build a friendship.
Not long ago I attended a dance at a stake that was not my own. The friend who invited me began introducing me to a group of girls standing near the door as we entered. Since I didn't know anyone, I was anxious to make some points with the ladies, so I said, "Wow. There sure are a lot of beautiful girls in your stake." My friend looked around the group and, trying to be funny, said loudly, "Where? Where? I don't see any." Needless to say, we were not the most popular guys at the dance that night.
People might put up with put-downs and manage a chuckle for the sake of saving face, but deep down, negative humor hurts.
If the above experience had been a scene on a TV show, my friend's "clever" comment would have been followed by laughter. In real life, the girls were offended and avoided us the rest of the evening. What many don't realize is that those producing TV shows use a laugh track—prerecorded laughter that can be turned on and off at the touch of a button. That's why laughter always follows sarcastic put-downs or mean jokes. It sounds like everyone enjoys the negative humor. In real life, there is no laugh track. People might put up with put-downs and manage a chuckle for the sake of saving face, but deep down, negative humor hurts. No matter how perfect the timing or how smoothly executed the joke, usually the only ones laughing are those who are afraid they may be your next targets.
Keeping a sense of humor helps us endure the trials of life. It is truly medicine to the soul (see Proverbs 17:22). However, not all humor is good humor. Elder Robert E. Wells wrote: "For some people, sharp questions or quick rejoinders are habits. Criticism is a form of humor for them, and they enjoy feeling superior when they see someone else's discomfort. This is a tragic, sinful attitude that must be changed" ("Overcoming Those Differences of Opinion," Ensign, Jan. 1987, 60–61).
I know one young woman who goes home feeling deflated and unimportant almost every night after being around a certain young man in her group of friends. He constantly makes fun of, criticizes, and belittles her. I asked her why she continues to spend time with him, and she responded: "He says I have to learn how to take a joke. I figure it's not worth losing friends over." I'm concerned about her decision to continue to be around this guy, and I wonder why he thinks he's so funny in the first place. How sad that she tries to cope with him rather than genuinely enjoying his company.
Brigham Young said that sarcastic and negative people "have little sense, and know not the difference between a happy smile of satisfaction to cheer the countenance of a friend, or a contemptuous sneer that brings the curses of man upon man" (Teachings of Presidents of the Church: Brigham Young [1997], 89).
We should be able to joke around with our friends, but there is a big difference between having fun with joking and making fun through joking. True friends help you feel better about yourself. They don't try to make themselves feel better at your expense. True friends enjoy mutual trust as much as they enjoy a good laugh. True friends allow you to let your guard down instead of always requiring you to keep your defenses up.
How do you know if your comments are building or hurting, just plain fun or crossing the line? Here is a test: How many times do you have to follow your comments up with the words "just kidding"? People think they can say whatever they want and then excuse their insensitivity with a quick, "Just kidding." It's a cop-out.
God did not send us here to degrade each other but to bless each other. The scriptures instruct us to strengthen one another in all our conversations (see D&C 108:7).
Most people realize that what they see on many TV programs is not real. They are able to recognize fake backdrops, fake snowflakes, and fake characters. So why is it so hard to recognize fake laughter? Negative humor hurts, and the resulting wounds go deep. In real life no one is laughing. Not really. Many remember careless comments for years. It's time to use humor in positive ways to build those around us, and I'm not just kidding.


text:
If someone wanted to learn more about the sixties, but didn't know where to start, these are the albums we'd recommend. While they aren't necessarily the best selling, or the most critically acclaimed, they are certainly the ones that float to the surface all these years later, providing a rough blueprint of era. Narrowing it down to just ten of course leaves out quite a bit (apologies to Pink Floyd, Frank Zappa, the Who, and pretty much the whole Motown catalogue), but this is a great starting point for anyone interested in what is perhaps the most important music decade of the 20th century.
See also: - Ten essential jazz albums if you know squat about jazz - Ten essential gangsta rap albums - The Beatles' Sgt Pepper inches toward the half-century mark - The Rolling Stones' Exile on Main Street turns 40 - The five best songs from the Summer of Love - The Jimi Hendrix Experience's Are You Experienced turns 45
1. The Beach Boys - Pet Sounds Challenging arrangements, complex vocal harmonies, psychedelic sound effects, existential, coming-of-age lyrics -- it has been said by many before us that Pet Sounds is the most essential album of the 1960s. Inspired by the Beatles' Rubber Soul, songsmith Brian Wilson set out to make "the greatest rock album of all time!" Wilson composed and recorded the arrangements for the album while his band-mates toured across Asia; and when they returned, Mike Love greeted Wilson's experimental, radio-unfriendly tunes as self-indulgent, druggy pap. This sentiment was shared by management, who put little promotion into the record, and record buyers, who failed to bring it to gold record status, greatly disappointing Wilson. Though across the pond Lennon and McCartney were far from disappointed, playing the album repeatedly for themselves and anyone who would listen, often citing it as a competitive influence on Sgt. Pepper. With treasured songs like "Wouldn't It Be Nice," "God Only Knows" and "Caroline, No" Brian Wilson created a template that would be emulated for decades to come, forever altering the emotional and sonic range of what could be done within a pop album.
If you like this story, consider signing up for our email newsletters.
You have successfully signed up for your selected newsletter(s) - please keep an eye on your mailbox, we're movin' in!

subset: commoncrawl


text:
Herring Revision of the Binet-Simon Tests and Verbal and Abstract Elements in Intelligence Examinations
Teachers college, Columbia university, 1924 - Binet-Simon Test - 72 pages
From inside the book
14 pages matching concrete and non-verbal in this book
Where's the rest of this book?
Results 1-3 of 14
What people are saying - Write a review
We haven't found any reviews in the usual places.
Statement of Problems
The Herring Revision of the BinetSimon Tests 1 Purposes of This Investigation
16 other sections not shown
Other editions - View all
Common terms and phrases
abilities Age 10 Age Army Beta Examination Beta Examination Grade Beta Maze Test Beta Pictorial Binet-Simon Tests Cl C2 C3 concrete and non-verbal Concrete-Abstract corre criteria criterion of intelligence Cross-Out Tests Thorndike Dearborn Intelligence Examination Educational Psychology equal Estimates of Intelligence Grade VII group examinations human behavior Indiana Cross-Out Tests individual examinations Individual Intelligence Examinations intelligence quotients involving IQ's measure of intelligence ment mental ages mental months Mental Survey mismeasure N. I. T. Arithmetical Problems N2 N3 Average National Intelligence Tests non-symbolic non-verbal tests obtained Pearson product points in IQ portion of scale problematical product moment correlation Pupil CI C2 r's of Table Revision rM N3 scale N Scatter Diagram situations Standard Deviations Stanford Binet Teachers College Test Beta test material Test N. I. T. Tests Thorndike Visual Thorndike Visual Vocabulary tion units validity verbal and abstract verbal tests Visual Vocabulary Grade Woody-McCall Arithmetic Test


text:
Culture Series is a premium corded headset solution for enterprises transitioning from traditional phone systems to Unified Communications. Single and dual-sided wearing styles are available, both in standard UC models and Skype for Business models.
Delivering maximum call-handling capability for UC environments!
Single-sided wearing style — lets you hear what's going on around you.Or Dual sided wearing style — for stereo HD sound reproduction in noisy environments.
Noise-canceling microphone — filters out ambient noise for optimum speech clarity.
HD Voice Clarity — with wideband sound for a natural listening experience.
High comfort — with large ear pads and a lightweight design for relaxed wearing.
Bendable boom arm — ensures microphone position is always optimal for clear audio. Cannot be twisted out of position.
Pivotable boom — rotates through 340 degrees for wearing flexibility on the right or left ear and precision microphone placement.
ActiveGard™ technology — protects you from acoustic shock and sudden sound surges.
Call control features — include answer/end a call, volume up/down, microphone mute, redial last outgoing call and reject incoming call.
2-year warranty — for peace-of-mind.


text:
From the very beginning of the orthopedic-chic shoe movement, Rachel Comey was there, bringing menswear-inspired, thick-soled clogs, boots, and sandals to PYTs who liked how insouciant a clunky shoe could make an outfit.
For her latest offering, she's delving into the whole sneaker craze, but doing it in a way that only Rachel could. With two styles and two colorways for each, these sneakers feature a white, rubber sole, leather uppers, and lacing you'd typically expect to see on an oxford, not a tennis shoe. If Nikes or Isabel Marants weren't your cup of tea, chances are Rachel could sway you to become a sneakerhead yet — click through to see!


text:
- Blush Crush Lounge Room
- Modern Chic Lounge Room
- Totally Tufted Lounge Room
- Cushy Indigo Lounge Room
- Caelan Lounge Room
- Gray Riley Lounge
- Indigo Baldwin Lounge
- Emily & Merritt Riley Lounge
- HARRY POTTER™ Sleepover
- HARRY POTTER™ HOGWARTS™ Pride Lounge
- Charcoal Tweed Cushy Lodge Lounge
- Playstation® Lounge
- Riley Iced Fur Blue Lounge
- Furlicious Faux-Fur Cushy Lounge
- Cement Riley Lounge
- Hello Kitty® Lounge Love
- White Avalon Lounge
- Lilly Pulitzer Happy Hangout Lounge
- Lily Pulitzer Sunny + Vibrant
- Antique Blue Stripe Prescott Lounge
- Charcoal Burnett Storage Lounge
- Ivory Sherpa Baldwin Lounge
- Bryce Channel Stitch Lounge
- Dusty Blush Riley Lounge
- Cushy Neutral Ground Lounge
- GRYFFINDOR™ Cushy Lounge
- Ivory Himalayan Avery Sectional Lounge
- Ivory Fox Riley Lounge
- Star Wars™ Baldwin Lounge
- NBA Bryce Lounge
- Ivivva Riley Lounge
- Polar Bear Ivory Roll Arm Cushy Lounge
- Bravado Baldwin Lounge
- Hang Around Small Space Lounge
- Cushy Coastal Inspired Lounge
- Bryce Makeover Lounge
- Beanbag Makeover Lounge
- Baldwin Poolside Lounge
- Emily & Meritt Cabana Lounge
- Emily & Meritt Poolside Lounge
- Riley Bryce Lounge
- Fur Rollarm Cushy Lounge
- Baldwin Lounge
- Navy Cushy Lounge
- Furlicious Cushy Lounge
- Desert Dreamer Cushy Lounge
- Cushy Denim Lounge
- Sherpa Baldwin Lounge
- Cushy Denim Lounge
Lounge Rooms
Everyone needs a place to relax. For one thing, you think better without stress. A quick nap on a comfy sofa the day before your big test makes it easier to concentrate. Of course, lounge rooms aren't just for laidback studying. They're also great spots for entertaining, whether it's snacks and a movie or a full-blown party. No matter what you use it for, at PBteen we want your lounge to look amazing. Check out some style ideas that help you put your personal touch on the room.
Infuse your lounge with furry sophistication. Our furlicious cushions add tons of chic to the space. They give it a supersoft feel that tickles your worries away. Thick, inviting sectionals let you customize the room however you want it. Their faux fur coverings aren't afraid to be bold. Use gold accents, vibrant colors and whatever says major bling to you. Blankets and decorative pillows in different shades of faux fur work really well.
For something warm, why not create a rustic cabin? Look for furniture featuring leather, faux suede and earthy tones. Anything that reminds you of camping around the fire is a good choice. Cozy faux fur blankets and sleeping bags keep everyone toasty in the winter whether having a sleepover or just enjoying a quick breakfast. This layout looks great in rooms with lots of natural lighting and wood. Finish things off with Western-inspired artwork and layered rugs.
Show off your creative side with an artistic escape. How do you turn a lounge into an artist's paradise? You need inspiration. Look through lots of designs until you see something that gives you awesome ideas. Your brain knows what it loves. Surround yourself in exciting colors and contours. Using sleek gray furniture as a base opens up endless decorating possibilities. And, of course, pick artwork that reflects your personality all around the lounge. Actually, we can even turn your own personalized creations into reality.
Kick back with a major beach vibe. Bright spaces make you happy, and so do deep cushions. To create a lounge that takes you to Miami Beach and back, focus on soothing blues, tropical greens and even orange. Keep things as light as possible so you feel the sunshine on your face. Decorate with surf motifs and sand-colored rugs. You can even hang your surfboard on the wall if you want to.
Fuse relaxation and chic with bright pink. It's a combination that's impossible to ignore. Roll arm furniture and tufted surfaces add a touch of vintage to the room, while also letting you choose tons of different layouts. Feel like sipping coffee and reading a book in a chaise? No problem. Or pose for stylish selfies in a chesterfield-inspired love seat with art prints in the background.


text:
Jennifer Lopez wowed everyone at the Grammy's on Sunday. Her pierna was the highlight of the night. Want to rock the leg loving trend try these tips.
Both Penelope Cruz and Hilaria Baldwin confirmed pregnancy rumors this week. We're officially on baby bump watch!
Mercedes Benz Fashion Week took over New York this week despite cold weather. Oscar de la Renta really made us proud, check out a few of our favorite looks from his Fall 2013 collection!
Want more from Krystyna? Follow her on Twitter @Krysty_C


text:
While small, compared to elk, butterflies are a colorful addition to Estes Park's wildlife.
A pair of bull elk jostle along the top of Trail Ridge. Bulls will often congregate along the ridge in summer.
Cows and a new calf wander through an open field in Estes Park. Elk have adapted to living close to humans in Estes Park.
A coyote peeks through flowrs and grass in the national park. The coyote is easily the most adaptable preditor in the area, having spread from the Southwest to almost every state of the union.
Deer fawns look for their mother through a fence in Carriage Hills in June.
A deer watches as people watch the deer.
A litter of fox kits plays with each other in spring grass. The small preditors tend to be shy and are often seen on the edges of the day.
A marmot suns himself on a rock on the alpine tundra. Marmots are one of the largest members of the rodent family.
A bighorn ram stands, almost posing, on Trail Ridge Road with Rocky Mountain National Park's other icon, Longs Peak.


text:
When I asked a couple of students what they were going to do with the photos and videos, they replied that they were going to show them to friends ands family, to explain what they were studying in university. They hadn't really thought about sharing anything , especially the videos, online as a teaching/learning resource for others.
What I would like to do one day in a research project is track is how students use these images and videos, and then explore what happens when the students proactively produce and publish images and videos online as a teaching/learning resource.
Have you heard of any similar projects? Are you a students who takes photos and videos at university/college? What do you do with them and why? Are you a teacher? How do your students use their cell phones?
Image: 'Communication'


text:
General Manager (Patrao)
Ealing Broadway
Salary: £32,000 - £42,000 plus bonus       •      Closing date: 06-03-2019      •      Ref: 6324
General Manager- Nando's - Ealing
At Nando's we like to create an environment that allows people to shine, enabling you to deliver amazing moments and feelings for every customer and team member. To help us achieve this, we recruit the very best General Managers- we call them Patraos, it's Portuguese for the head of the family.
As head of the family, you'll take full accountability for your restaurant, your team members, setting the restaurant's agenda, fulfilling the Nando's plan and ultimately growing business performance.
About you – What qualities does a General Manager (Patrao) need to join Nando's?
• You'll have general management experience from a hospitality, retail or leisure background
• You'll have bucket-loads of passion and energy to inspire, lead and develop your Nandocas. (That's team members in Nando's speak)
• Desire to drive sales and use your personality to network with local businesses and make our customers feel like Nando's is their home from home
• You`ll be hungry to learn and develop yourself & your team, ready to grow as fast as Nando`s does!
• Above everything else, you`ll live the Nando`s values of Pride, Passion, Integrity, Courage and Family. You'll also be ready for some serious fun!
It pays to be a General Manager (Patrao)
• Generous bonus package
• 28 days holiday
• 4 week sabbatical after every 5 years
• 40% discount Monday – Thursday and 20% discount Friday – Sunday at all Nando's restaurants when visiting with up to 5 guests
• Free Nando's on days worked
• Healthcare and contributory pension scheme
• Conference (well when we say conference we've been to South Africa, Brazil…)
• Quarterly regional drinks evenings – including a themed Christmas party for all Nandocas
• Annual family fun day – all Nandocas can invite their families for a party in the park!
• Become a Partner of Nando's and earn even more
• The chance to get tax savings on a bike via the Cycle to work scheme
• Discounts on some great brands with Perkbox
Sorry, this vacancy is closed.


text:
Department of Health and Human Services
Participating Organizations
National Institutes of Health (NIH), (http://www.nih.gov)
Substance Abuse and Mental Health Services Administration (SAMHSA), (http://www.samhsa.gov)
of Participating Organizations
National Institute on Drug Abuse (NIDA), (http://www.nida.nih.gov)
Title: Screening, Brief Intervention and Referral to Treatment (SBIRT) for Drug Abuse in General Medical Settings (R01)
Announcement Type
NOTICE: Applications submitted in response to this Funding Opportunity Announcement (FOA) for Federal assistance must be submitted electronically through Grants.gov (http://www.grants.gov) using the SF424 Research and Related (R&R) forms and the SF424 (R&R) Application Guide
This FOA must be read in conjunction with the application guidelines included with this announcement in Grants.gov/Apply for Grants (hereafter called Grants.gov/Apply).
A registration process is necessary before submission and applicants are highly encouraged to start the process at least four weeks prior to the grant submission date. See Section IV.
Request for Applications (RFA) Number: RFA-DA-08-021
Catalog of Federal Domestic Assistance Number(s)
Key Dates
Release/Posted Date: January 3, 2008
Opening Date: Month, day, year (Earliest date an application may be submitted to Grants.gov) February 14, 2008
Letters of Intent Receipt Date(s): February 14, 2008
NOTE: On time submission requires that applications be successfully submitted to Grants.gov no later than 5:00 p.m. local time (of the applicant institution/organization).
Application Submission/Receipt Date(s): March 14, 2008
Peer Review Date(s): June/July, 2008
Council Review Date(s): August 2008
Earliest Anticipated Start Date(s): September 30, 2008
Expiration Date: March 15, 2008
Due Dates for
Not Applicable
Additional Overview Content
Executive Summary
Table of Contents
Part I Overview Information
Part II Full Text of Announcement
Section I. Funding Opportunity Description
1. Research Objectives
Section II. Award Information
1. Mechanism of Support
2. Funds Available
Section III. Eligibility Information
1. Eligible Applicants
A. Eligible Institutions
B. Eligible Individuals
2. Cost Sharing or Matching
3. Other-Special Eligibility Criteria
Section IV. Application and Submission Information
1. Request Application Information
2. Content and Form of Application Submission
3. Submission Dates and Times
A. Submission, Review, and Anticipated Start Dates
1. Letter of Intent
B. Submitting an Application Electronically to the NIH
C. Application Processing
4. Intergovernmental Review
5. Funding Restrictions
6. Other Submission Requirements
Section V. Application Review Information
1. Criteria
2. Review and Selection Process
A. Additional Review Criteria
B. Additional Review Considerations
C. Sharing Research Data
D. Sharing Research Resources
3. Anticipated Announcement and Award Dates
Section VI. Award Administration Information
1. Award Notices
2. Administrative and National Policy Requirements
3. Reporting
Section VII. Agency Contacts
1. Scientific/Research Contact(s)
2. Peer Review Contact(s)
3. Financial/Grants Management Contact(s)
Section VIII. Other Information - Required Federal Citations
Part II - Full Text of Announcement
Section I. Funding Opportunity Description
1. Research Objectives
The National Institute on Drug Abuse (NIDA) in conjunction with the Center for Substance Abuse Treatment (CSAT)
of the Substance Abuse and Mental
Health Services Administration (SAMHSA), invites Research Project Grant (R01) Applications to develop or adapt, and test the effectiveness of comprehensive models of care that integrate screening, brief intervention, and referral to specialized treatment (SBIRT) for drug abusing and addicted individuals entering into general medical care settings. The term general medical care includes all settings where non-specialty medical care is provided on an in- or out- patient basis. Responsive applications will include studies on SBIRT which are designed to show an impact on both the medical and social consequences of drug use to patients in general medical care settings. Illicit drugs, including prescription drug misuse, must be a primary focus of a responsive application although alcohol and/or nicotine may be included. In particular, this RFA encourages randomized clinical trials on SBIRT compared to general medical care as usual or screening only (without intervention). Studies should be designed to show the impact of SBIRT on: drug use; mortality and morbidity of chronic disease; HIV risk behaviors and/or HIV incidence or transmission; health care utilization, and/or changes in economic measures (such as economic gains by the patient or/his her family, return to work by disabled patients, and changes in medical or social service costs). SBIRT has been shown to be effective for alcohol abuse and tobacco use, and as a result is currently a standard practice in many general medical settings for these conditions, but not for drug abuse. Studies that determine the effectiveness of screening and intervention approaches for drug abuse incorporated into these existing practice settings are particularly encouraged, as are studies that explore ways to maximize the potential efficiencies derived by linking SBIRT models for drug abuse to these established interventions for alcohol and tobacco. An important result of this work is expected to be evidence-based techniques elucidating methods to effectively integrate and implement these different SBIRT components and demonstrating a specific impact on drug abuse and addiction.
This RFA is a joint effort between the (NIDA) and (CSAT) / (SAMHSA). As such, applicants are encouraged to utilize the SAMHSA – SBIRT Initiative system (RFA No. TI03-009) http://www.samhsa.gov/newsroom/advisories/0711271609.aspx that is currently funded and will continue to be operational in various sites around the country during the course of this RFA. A major goal of this RFA is to encourage studies that will provide the most definitive evidence of the effectiveness, accessibility, utilization, quality, cost, and cost-effectiveness of the SBIRT models of care; therefore, randomized controlled clinical trials are strongly preferred. The Research Project Grant (R01) funding mechanism will be employed exclusively to provide the necessary resources to perform such studies. Applicants must also provide evidence for a successful collaboration with the medical care setting where they will conduct the proposed research studies.
For the purposes of this RFA, the term "general medical care setting" includes multiple forms of health-care facilities that are initially accessed by patients. These settings include outpatient clinics, emergency rooms, acute care facilities (public and/or private), community health centers, school-based health clinics, occupational health clinics, and private practices that offer office-based general medical care. The health care providers in these facilities include primary care clinicians which may include allopathic or osteopathic physicians, nurse practitioners, and physician assistants-but also involving a broader array of individuals in a care team including nurses, social workers, and behavioral health practitioners. A number of the following medical specialties may practice general medicine, including: pediatrics, adolescent medicine, internal medicine, general medicine, and family practice (other specialties may also be included when practicing general medicine).
This RFA specifically excludes research that will be conducted at addiction treatment facilities.
Substance abuse prevention and treatment traditionally have been delivered through separate specialty systems in distinct settings. Most of the individuals who require substance abuse treatment do not seek this care. However the majority of substances abusing individuals do come into contact with the general medical care system on a regular basis. For this reason, general medical settings are potentially one of the key points of access to screening, assessment, early intervention, referral, and treatment for individuals who present with a spectrum of substance use issues.
SBIRT is a comprehensive and integrated public health approach to detect and deliver a spectrum of early detection and treatment services for problem substance use and related health problems, including HIV/AIDS, in general medical care settings. NIDA conceptualizes SBIRT for drug abuse and addiction as a constellation of intervention approaches that use reliable and validated tools for identifying people with problem drug use and which provide a brief intervention as either a precursor to formal addiction treatment, or as a stand alone treatment depending on the severity of the substance use disorder and the availability of treatment resources in the community. The screening tool(s) may involve one or several items but should be suitable for administration within the constraints of a general medical setting. Brief interventions are expected to include one or several sessions of counseling regarding the use of abused substances. The expectation is for consistent sessions based on tested and proven approaches to behavior change that contain more than advice to stop the behavior.
The SBIRT process is accepted as effective for the reduction of problem drinking and tobacco use by various Public Health agencies of the United States Department of Health and Human Services and numerous medical specialty societies. Several SBIRT models have been shown to be effective in improving outcomes of persons with problematic alcohol and nicotine use in general medical care settings (Kaner, E., et al., Effectiveness of brief alcohol interventions in primary care populations (Review) The Cochrane Library, 2007(3)). This request for applications (RFA) seeks to extend this work to determine the effectiveness of SBIRT models of care for reducing drug abuse and its related health and HIVAIDS consequences in general medical settings.
To determine the effectiveness of this approach for various health behaviors, a formal evaluation by the United States Public Health Service Task Force (USPSTF) was undertaken for the Agency for Healthcare Research and Quality (AHRQ). It was determined that the evidence base to support the use of SBIRT for problem alcohol and tobacco use existed. However, few findings supporting SBIRT for illicit drug use exist; furthermore, there is no specific research regarding SBIRT and the growing problem of prescription drug abuse. In 1995, the last AHRQ report evaluating SBIRT effectiveness for drugs found: "Insufficient evidence to recommend for or against". Little evidence has accumulated since this time.
A number of barriers exist (organizational, financial, clinical, ethical and legal) to implementing SBIRT services into medical settings. Medical providers often fail to associate behavioral problems, psychosocial problems, mood disturbances, dysfunctional eating, occupational or academic underachievement, sexually transmitted diseases, and other common presenting problems with drug use and abuse in their patients. Similarly, physicians routinely faced with the many medical consequences of drug abuse such as HIV/AIDS and other sexually transmitted diseases, hepatitis and other infectious diseases, heart attacks, and pulmonary problems are not aware of the impact of drug use and abuse on these medical conditions. It has been shown that medical care providers have begun to address the clinical symptoms and medical consequences of problematic alcohol and tobacco use as an integral part of patient care, but they seldom screen for, or even acknowledge, the use and abuse of illicit drugs (e.g., marijuana, heroin, cocaine, methamphetamine, hallucinogens, club drugs, inhalants), and may even more rarely address the problem of prescription drug use.
Furthermore, little research has examined effective ways to educate and encourage practicing medical providers to address problem drug use, abuse, and related health conditions in their standard care routines. Research has not yet systematically assessed the effectiveness and impact on practice behaviors of the limited post-graduate training related to drug abuse and addiction that is typically available. Also lacking is research on practical incentives for medical providers to focus on problem drug use as a treatment priority. It is unclear the extent to which the current lack of attention to problem drug use in medical settings is related to factors such as the stigmatized nature of drug use and its associated problems; lack of efficacious tools for screening, assessing, preventing, or treating problematic drug use in medical settings; lack of health care provider training about substance use disorders and associated medical and mental health consequences and interventions; and/or organizational, management, or financing issues, including limited reimbursement for care.
To achieve successful implementation and sustainability of SBIRT systems organizational changes must occur. Organizational change methods and processes are well described in the literature including quality improvement, management science, and implementation and technology transfer. Researchers unfamiliar with this literature should consider collaborating with colleagues experienced in organizational change/development. However, specific organizational change models suitable for integrating the SBIRT model into community based medical clinics have not been clearly elucidated. Greater understanding of organizational change is important to achieve successful implementation of SBIRT for patients encountered in a general medical practice—ranging from those that have relatively minimal drug use histories to those who are addicted.
Specific Research Areas of Interest:
NIDA is interested in the development or adaptation, and testing of specific SBIRT models of care to improve treatment availability for persons with drug abuse and addiction, and to decrease the morbidity and mortality that results from drug use. Testing the effectiveness of these interventions is a mandatory part of the required study design. Specifically NIDA seeks randomized clinical trials on SBIRT compared to general medical care as usual or screening only (without intervention). The design should define the impact of SBIRT on key measured variables such as: mortality and morbidity of chronic disease; HIV risk behaviors, incidence or transmission; health care utilization; and/or changes in economic measures such as economic gains by the patient or/his her family, return to work and reductions in medical or social service costs.
NIDA encourages applicants to conduct research in collaboration with with the SAMHSA/CSAT SBIRT grantees (RFA No. TI 03-009). There are eleven existing CSAT Cooperative Agreements, and it is anticipated that four new agreements will be awarded in FY 2008. The original cohort of seven SBIRT state agreements include California, Cook Inlet Tribal Council Alaska, Illinois, New Mexico, Pennsylvania, Texas, Washington. These grants are in the final year of funding. The four state cooperative agreements in the second cohort that became operational in 2007 are with Colorado, Florida, Massachusetts and Wisconsin. Applicants should visit the CSAT/SBIRT website for information on these projects and SBIRT (http://sbirt.samhsa.gov) and http://www.samhsa.gov/newsroom/advisories/0711271609.aspx .
It is also important to recognize that drug abuse and addiction often co-occur with alcohol and tobacco use and addiction as well as multiple other behavioral conditions. Screening intervention approaches that take advantage of potential efficiencies by linking existing SBIRT models for these conditions simultaneously are particularly encouraged. The ultimate results of this program of work are expected to include evidence about how to effectively integrate and implement these different components while still demonstrating a specific impact on illicit drug use and addiction.
Areas of specific interest include but are not limited to:
Special Considerations
HIV/AIDS Counseling and Testing Policy for the National Institute on Drug Abuse: In light of recent significant advances in rapid testing for HIV and in effective treatments for HIV, NIDA has revised its 2001 policy on HIV counseling and testing. NIDA-funded researchers are strongly encouraged to provide and/or refer research subjects to HIV risk reduction education and education about the benefits of HIV treatment, counseling and testing, referral to treatment, and other appropriate interventions to prevent acquisition and transmission of HIV. This policy applies to all NIDA funded research conducted domestically or internationally. For more information see https://grants.nih.gov/grants/guide/notice-files/NOT-DA-07-013.html.
National Advisory Council on Drug Abuse Recommended Guidelines for the Administration of Drugs to Human Subjects: The National Advisory Council on Drug Abuse (NACDA) recognizes the importance of research involving the administration of drugs with abuse potential, and dependence or addiction liability, to human subjects. Potential applicants are encouraged to obtain and review these recommendations of Council before submitting an application that will administer compounds to human subjects. The guidelines are available on NIDA's Web site at http://www.nida.nih.gov/about/organization/nacda/CouncilStatement.html
See Section VIII, Other Information - Required Federal
Citations, for policies related to this
Section II. Award Information
1. Mechanism of Support
This Funding Opportunity Announcement (FOA) will use the NIH Research Project Grant (R01) award mechanism.
The applicant will be solely responsible for planning, directing, and executing the proposed project.
This FOA uses "Just-in-Time" information concepts. It also uses the modular as well as the non-modular budget formats (see https://grants.nih.gov/grants/funding/modular/modular.htm). Specifically, if you are a U.S. organization and are submitting an application with direct costs in each year of $250,000 or less (excluding consortium Facilities and Administrative [F&A] costs), use the PHS398 Modular Budget component provided in the SF424 (R&R) Application Package and SF424 (R&R) Application Guide (see specifically Section 5.4, "Modular Budget Component," of the Application Guide).
U.S. applicants requesting more than $250,000 in annual direct costs and all foreign applicants must complete and submit budget requests using the Research & Related Budget component found in the application package for this FOA. See NOT-OD-06-096, August 23, 2006.
2. Funds Available
Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. Although the financial plans of the Institutes and Centers (ICs) provide support for this program, awards pursuant to this funding opportunity are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
The participating organization(s) NIDA and CSAT/SAMHSA intend to commit approximately 3.5 million dollars in total costs [Direct plus Facilities and Administrative (F & A) costs] in FY 2008 to fund six to eight new grants in response to this RFA.
NIH grants
policies as described in the NOT-OD-05-004,
November 2, 2004.
Section III. Eligibility Information
1. Eligible Applicants
for renewal or supplementation of existing projects and resubmission (amended)
applications are not eligible to compete with applications for new awards.
1.A. Eligible Institutions
You may submit an application(s) if your institution/organization has any of the following characteristics:
1.B. Eligible Individuals
Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the PD/PI is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.
More than one PD/PI, or multiple PDs/PIs, may be designated on the application for projects that require a "team science" approach that clearly does not fit the single-PD/PI model. Additional information on the implementation plans and policies and procedures to formally allow more than one PD/PI on individual research projects is available at https://grants.nih.gov/grants/multi_pi. All PDs/PIs must be registered in the NIH eRA Commons prior to the submission of the application (see http://era.nih.gov/ElectronicReceipt/preparing.htm for instructions).
The decision of whether to apply for a single PD/PI or multiple PD/PI grant is the responsibility of the investigators and applicant organizations and should be determined by the scientific goals of the project. Applications for multiple PD/PI grants will require additional information, as outlined in the instructions below. The NIH review criteria for approach, investigators, and environment have been modified to accommodate applications involving either a single PD/PI or multiple PDs/PIs. When considering multiple PDs/PIs, please be aware that the structure and governance of the PD/PI leadership team as well as the knowledge, skills and experience of the individual PD/PIs will be factored into the assessment of the overall scientific merit of the application. Multiple PDs/PIs on a project share the authority and responsibility for leading and directing the project, intellectually and logistically. Each PD/PI is responsible and accountable to the grantee organization, or, as appropriate, to a collaborating organization, for the proper conduct of the project or program, including the submission of required reports. For further information on multiple PDs/PIs, please see https://grants.nih.gov/grants/multi_pi.
2. Cost Sharing or Matching
This program does not require cost sharing as defined in the current NIH Grants Policy Statement.
3. Other-Special Eligibility Criteria
Applicants may submit more than one application, provided each application is scientifically distinct. More than one PD/PI, or multiple PDs/PIs, may be designated on the application.
Resubmissions (formerly "revisions/amendments') will not be accepted under this RFA. All applications should be new unique submissions. At this time it is not known whether or not this RFA will be reissued.
Section IV. Application and Submission Information
To download a SF424
(R&R) Application Package and SF424 (R&R) Application Guide for
completing the SF424 (R&R) forms for this FOA, link to http://www.grants.gov/web/grants/applicants/apply-for-grants.html and follow the directions provided on that Web site.
A one-time registration is required for institutions/organizations at both:
PDs/PIs should work with their institutions/organizations to make sure they are registered in the eRA Commons.
Several additional separate actions are required before an applicant institution/organization can submit an electronic application, as follows:
1) Organizational/Institutional Registration in Grants.gov/Get Registered
2) Organizational/Institutional Registration in the eRA Commons
3) Project Director/Principal Investigator (PD/PI) Registration in the NIH eRA Commons: Refer to the NIH eRA Commons System (COM) Users Guide.
Both the PD/PI(s) and AOR/SO need separate accounts in the NIH eRA Commons since both are authorized to view the application image.
Note that if a PD/PI is also an NIH peer-reviewer with an Individual DUNS and CCR registration, that particular DUNS number and CCR registration are for the individual reviewer only. These are different than any DUNS number and CCR registration used by an applicant organization. Individual DUNS and CCR registration should be used only for the purposes of personal reimbursement and should not be used on any grant applications submitted to the Federal Government.
Several of the steps of the registration process could take four weeks or more. Therefore, applicants should immediately check with their business official to determine whether their organization/institution is already registered in both Grants.gov and the Commons. The NIH will accept electronic applications only from organizations that have completed all necessary registrations.
1. Request Application Information
Applicants must download the SF424 (R&R) application forms and the SF424 (R&R) Application Guide for this FOA through Grants.gov/Apply.
Only the forms package directly attached to a specific FOA can be used. You
will not be able to use any other SF424 (R&R) forms (e.g., sample forms,
forms from another FOA), although some of the "Attachment" files may
be useable for more than one FOA.
For further assistance, contact GrantsInfo: Telephone 301-710-0267, Email: email@example.com.
Telecommunications for the hearing impaired: TTY 301-451-5936.
2. Content and Form of Application Submission
Prepare all applications using the SF424 (R&R) application forms and in accordance with the SF424 (R&R) Application Guide for this FOA through Grants.gov/Apply.
The SF424 (R&R) Application Guide is critical to submitting a complete and accurate application to NIH. There are fields within the SF424 (R&R) application components that, although not marked as mandatory, are required by NIH (e.g., the "Credential" log-in field of the "Research & Related Senior/Key Person Profile" component must contain the PD/PI's assigned eRA Commons User ID). Agency-specific instructions for such fields are clearly identified in the Application Guide. For additional information, see "Frequently Asked Questions – Application Guide, Electronic Submission of Grant Applications."
The SF424 (R&R) application has several components. Some components are required, others are optional. The forms package associated with this FOA in Grants.gov/APPLY includes all applicable components, required and optional. A completed application in response to this FOA includes the data in the following components:
Required Components:
SF424 (R&R) (Cover component)
Research & Related Project/Performance Site Locations
Research & Related Other Project Information
Research & Related Senior/Key Person
PHS398 Cover Page Supplement
PHS398 Research Plan
PHS398 Checklist
PHS398 Modular Budget or Research & Related Budget, as appropriate (See Section IV.6., "Special Instructions," regarding appropriate required budget component.)Research & Related Budget (required for foreign applications)
Optional Components:
PHS398 Cover Letter File
Research & Related Subaward Budget Attachment(s) Form
Organizations (Non-domestic (non-U.S.) Entity)
NIH policies concerning grants to foreign (non-U.S.) organizations can be found in the NIH Grants Policy Statement at: https://grants.nih.gov/archive/grants/policy/nihgps_2003/index.htm#_Toc54600260.
Foreign institutions and international organizations, including public or private non-profit or for-profit organizations, are eligible to apply for this RFA if at least one U.S. site will be studied, and is included in the research plan.
Applications from foreign organizations must:
Proposed research should provide special opportunities for furthering research programs through the use of unusual talent, resources, populations, or environmental conditions in other countries that are not readily available in the United States or that augment existing U.S. resources.
Applications with Multiple PDs/PIs
When multiple PDs/PIs are proposed, NIH requires one PD/PI to be designated as the "Contact" PI, who will be responsible for all communication between the PDs/PIs and the NIH, for assembling the application materials outlined below, and for coordinating progress reports for the project. The contact PD/PI must meet all eligibility requirements for PD/PI status in the same way as other PDs/PIs, but has no other special roles or responsibilities within the project team beyond those mentioned above.
Information for the Contact PD/PI should be entered in item 15 of the SF424 (R&R) Cover component. All other PDs/PIs should be listed in the Research & Related Senior/Key Person component and assigned the project role of "PD/PI." Please remember that all PDs/PIs must be registered in the eRA Commons prior to application submission. The Commons ID of each PD/PI must be included in the "Credential" field of the Research & Related Senior/Key Person component. Failure to include this data field will cause the application to be rejected.
All projects proposing Multiple PDs/PIs will be required to include a new section describing the leadership of the project.
Multiple PD/PI Leadership Plan: For applications designating multiple PDs/PIs, a new section of the research plan, entitled "Multiple PD/PI Leadership Plan" (section 14 of the Research Plan Component in the SF424 (R&R) or Section I of the Research Plan in the PHS 398), must be included. A rationale for choosing a multiple PD/PI approach should be described. The governance and organizational structure of the leadership team and the research project should be described, including communication plans, process for making decisions on scientific direction, and procedures for resolving conflicts. The roles and administrative, technical, and scientific responsibilities for the project or program should be delineated for the PDs/PIs and other collaborators.
If budget allocation is planned, the distribution of resources to specific components of the project or the individual PDs/PIs should be delineated in the Leadership Plan. In the event of an award, the requested allocations may be reflected in a footnote on the Notice of Award.
Applications Involving a Single Institution
When all PDs/PIs are within a single institution, follow the instructions contained in the SF424 (R&R) Application Guide.
Applications Involving Multiple Institutions
When multiple institutions are involved, one institution must be designated as the prime institution and funding for the other institution(s) must be requested via a subcontract to be administered by the prime institution. When submitting a detailed budget, the prime institution should submit its budget using the Research & Related Budget component. All other institutions should have their individual budgets attached separately to the Research & Related Subaward Budget Attachment(s) Form. See Section 4.8 of the SF424 (R&R) Application Guide for further instruction regarding the use of the subaward budget form.
When submitting a modular budget, the prime institution completes the PHS398 Modular Budget component only. Information concerning the consortium/subcontract budget is provided in the budget justification. Separate budgets for each consortium/subcontract grantee are note required when using the Modular budget format. See Section 5.4 of the Application Guide for further instruction regarding the use of the PHS398 Modular Budget component.
3. Submission Dates and Times
See Section IV.3.A. for details.
3.A. Submission, Review, and Anticipated Start Dates
Opening Date: (Earliest date an application may be submitted to Grants.gov) February 14, 2008
Letters of Intent Receipt Date: February 14, 2008
Application Submission/Receipt Date(s): March 14, 2008
Peer Review Date(s): June-July, 2008
Council Review Date(s): August 2008
Earliest Anticipated Start Date(s): September 30, 2008
3.A.1. Letter of Intent
Prospective applicants are asked to submit a letter of intent that includes the following information:
a letter of intent is not required, is not binding, and does not enter into the
review of a subsequent application, the information that it contains allows IC
staff to estimate the potential review workload and plan the review.
The letter of intent is to be sent by the date listed in Section IV.3.A.
The letter of intent should be sent to:
Director, Office of Extramural Affairs
National Institute on Drug Abuse/NIH/DHHS
6101 Executive Boulevard, Suite 220, MSC 8401
Bethesda, MD 20892-8401
Rockville, MD 20852 (for express/courier service)
Telephone: (301) 443-2755
Email: email@example.com
3.B. Submitting an Application Electronically to the NIH
To submit an application in response to this FOA, applicants should access this FOA via http://www.grants.gov/web/grants/applicants/apply-for-grants.html and follow steps 1-4. Note: Applications must only be submitted electronically. PAPER APPLICATIONS WILL NOT BE ACCEPTED.
In order to expedite the review, applicants are requested to notify the NIDA Referral Office by email (email@example.com) when the application has been submitted. Please include the FOA number and title, PD/PI name, and title of the application.
3.C. Application Processing
Applications may be submitted on or after the opening date and must be successfully received by Grants.gov no later than 5:00 p.m. local time (of the applicant institution/organization) on the application submission/receipt date(s). (See Section IV.3.A. for all dates.) If an application is not submitted by the receipt date(s) and time, the application may be delayed in the review process or not reviewed.
Once an application package has been successfully submitted through Grants.gov, any errors have been addressed, and the assembled application has been created in the eRA Commons, the PD/PI and the Authorized Organization Representative/Signing Official (AOR/SO) have two business days to view the application image.
Upon receipt, applications will be evaluated for completeness by the CSR and responsiveness by NIDA. Incomplete and non-responsive applications will not be reviewed.
There will be an acknowledgement of receipt of applications from Grants.gov and the Commons. The submitting AOR receives the Grants.gov acknowledgments. The AOR and the PI receive Commons acknowledgments. Information related to the assignment of an application to a Scientific Review Group is also in the Commons.
Note: Since email can be unreliable, it is the responsibility of the applicant to check periodically on their application status in the Commons.
The NIH will not accept any application in response to this funding opportunity that is essentially the same as one currently pending initial review, unless the applicant withdraws the pending application. However, when a previously unfunded application, originally submitted as an investigator-initiated application, is to be submitted in response to a funding opportunity, it is to be prepared as a NEW application. That is, the application for the funding opportunity must not include an "Introduction" describing the changes and improvements made, and the text must not be marked to indicate the changes from the previous unfunded version of the application.
4. Intergovernmental Review
This initiative is not subject to intergovernmental review.
5. Funding Restrictions
All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.
Costs are allowable. A grantee may, at its own risk and without NIH prior
approval, incur obligations and expenditures to cover costs up to 90 days
before the beginning date of the initial budget period of a new or competing
renewal (formerly "competing continuation") award if such costs: are necessary
to conduct the project, and would be allowable under the grant, if awarded,
without NIH prior approval. If specific expenditures would otherwise require
prior approval, the grantee must obtain NIH approval before incurring the cost.
NIH prior approval is required for any costs to be incurred more than 90 days
before the beginning date of the initial budget period of a new or competing
renewal award.
The incurrence of pre-award costs in anticipation of a competing or non-competing award imposes no obligation on NIH either to make the award or to increase the amount of the approved budget if an award is made for less than the amount anticipated and is inadequate to cover the pre-award costs incurred. NIH expects the grantee to be fully aware that pre-award costs result in borrowing against future support and that such borrowing must not impair the grantee's ability to accomplish the project objectives in the approved time frame or in any way adversely affect the conduct of the project. See the NIH Grants Policy Statement.
6. Other Submission Requirements
PD/PI Credential (e.g., Agency Login)
The NIH requires the PD/PI(s) to fill in his/her Commons User ID in the "PROFILE – Project Director/Principal Investigator" section, "Credential" log-in field of the "Research & Related Senior/Key Person Profile" component.
Organizational DUNS
The applicant organization must include its DUNS number in its Organization Profile in the eRA Commons. This DUNS number must match the DUNS number provided at CCR registration with Grants.gov. For additional information, see "Frequently Asked Questions – Application Guide, Electronic Submission of Grant Applications."
PHS398 Research Plan Component Sections
Items 2-5 of the PHS398 Research Plan component are limited to 25 pages. While each section of the Research Plan component needs to be uploaded separately as a PDF attachment, applicants are encouraged to construct the Research Plan component as a single document, separating sections into distinct PDF attachments just before uploading the files. This approach will enable applicants to better monitor formatting requirements such as page limits. All attachments must be provided to NIH in PDF format, filenames must be included with no spaces or special characters, and a .pdf extension must be used.
All application instructions outlined in the SF424 (R&R) Application Guide are to be followed, incorporating "Just-in-Time" information concepts, and with the following additional requirements:
Special Instructions for Modular Grant applications
R01 applications from U.S. institutions/organizations requesting up to $250,000 per year in direct costs (excluding consortium F&A costs) must be submitted in a modular budget format. Additional information on modular budgets is available at https://grants.nih.gov/grants/funding/modular/modular.htm. When submitting a modular budget, the applicant organization will include only the PHS398 Modular Budget component. See Section 5.4 of the SF424 (R&R) Application Guide for further instructions regarding the use of the PHS398 Modular Budget component.
Foreign organizations may not submit modular budgets. See NOT-OD-06-096.
Appendix Materials
NIH has published new limitations on grant application appendix materials to encourage applications to be as concise as possible while containing the information needed for expert scientific review. See https://grants.nih.gov/grants/guide/notice-files/NOT-OD-07-018.html.
Applicants must follow the specific instructions on Appendix materials as described in the SF424 (R&R) Application Guide (See https://grants.nih.gov/grants/funding/424/index.htm).
Do not use the Appendix to circumvent the page limitations of the Research Plan component. An application that does not observe the required page limitations may be delayed in the review process.
Note: While each section of the PHS398 Research Plan component needs to be uploaded separately as a PDF attachment, applicants are encouraged to construct the Research Plan component as a single document, separating sections into distinct PDF attachments just before uploading the files. This approach will enable applicants to monitor better formatting requirements such as page limits. All attachments must be provided to NIH in PDF format, filenames must be included with no spaces or special characters, and a .pdf extension must be used.
Foreign Applications (Non-domestic (non-U.S.) Entity)
Plan for Sharing Research Data
precise content of the data-sharing plan will vary, depending on the data being
collected and how the investigator is planning to share the data. Applicants
who are planning to share data may wish to describe briefly the expected
schedule for data sharing, the format of the final dataset, the documentation
to be provided, whether or not any analytic tools also will be provided,
whether or not a data-sharing agreement will be required and, if so, a brief
description of such an agreement (including the criteria for deciding who can
receive the data and whether or not any conditions will be placed on their
use), and the mode of data sharing (e.g., under their own auspices by mailing a
disk or posting data on their institutional or personal Web site, through a
data archive or enclave). Investigators choosing to share under their own
auspices may wish to enter into a data-sharing agreement. References to data
sharing may also be appropriate in other sections of the application.
Applicants requesting more than $500,000 in direct costs in any year of the proposed research must include a plan for sharing research data in their application. The funding organization will be responsible for monitoring the data sharing policy (https://grants.nih.gov/grants/policy/data_sharing).
The reasonableness of the data sharing plan or the rationale for not sharing research data may be assessed by the reviewers. However, reviewers will not factor the proposed data sharing plan into the determination of scientific merit or the priority score.
Sharing Research Resources
policy requires that grant awardee recipients make unique research resources
readily available for research purposes to qualified individuals within the
scientific community after publication (See the NIH Grants Policy Statement https://grants.nih.gov/archive/grants/policy/nihgps_2003/index.htm#_Toc54600131).
Investigators responding to this funding opportunity should include a sharing
research resources plan addressing how unique research resources will be shared
or explain why sharing is not possible.
The adequacy of the resources sharing plan and any related data sharing plans will be considered by Program staff of the funding organization when making recommendations about funding applications. The effectiveness of the resource sharing will be evaluated as part of the administrative review of each Non-Competing Grant Progress Report (PHS 2590). See Section VI.3., "Reporting."
Section V. Application Review Information
1. Criteria
Only the review criteria described below will be considered in the review process.
2. Review and Selection Process
Applications that are complete and responsive to the FOA will be evaluated for scientific and technical merit by an appropriate peer review group convened by NIDA in accordance with the review criteria stated below.
As part of the initial merit review, all applications will:
Applications submitted in response to this funding opportunity will compete for available funds with all other recommended applications. The following will be considered in making funding decisions:
The goals of NIH supported research are to advance our understanding of biological systems, to improve the control of disease, and to enhance health. In their written critiques, reviewers will be asked to comment on each of the following criteria in order to judge the likelihood that the proposed research will have a substantial impact on the pursuit of these goals. Each of these criteria will be addressed and considered in assigning the overall score, weighting them as appropriate for each application.
Note that an
application does not need to be strong in all categories to be judged likely to
have major scientific impact and thus deserve a high priority score. For
example, an investigator may propose to carry out important work that by its
nature is not innovative but is essential to move a field forward.
Significance: Does this study address an important problem? If the aims of the application are achieved, how will scientific knowledge or clinical practice be advanced? What will be the effect of these studies on the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field?
Will this study
significantly impact
medical and/or
social consequences of drug use of patients in general medical care settings?
How will this study utilize state of the art methodology to create a strong
evidence base to address the important policy and practice gaps regarding SBIRT
models of care?
Approach: Are the conceptual or clinical framework, design, methods, and analyses adequately developed, well integrated, well reasoned, and appropriate to the aims of the project? Does the applicant acknowledge potential problem areas and consider alternative tactics? Is the research design appropriate to effectively address the aims of the study? For applications designating multiple PDs/PIs, is the leadership approach, including the designated roles and responsibilities, governance, and organizational structure, consistent with and justified by the aims of the project and the expertise of each of the PDs/PIs?
Innovation: Is the project original and innovative? For example: Does the project challenge existing paradigms or clinical practice; address an innovative hypothesis or critical barrier to progress in the field? Does the project develop or employ novel concepts, approaches, methodologies, tools, or technologies for this area?
Investigators: Are the PD/PI(s) and other key personnel appropriately
trained and well suited to carry out this work? Is the work proposed appropriate
to the experience level of the principal investigator and other researchers?
Does the PD/PI(s) and investigative team bring complementary and integrated
expertise to the project (if applicable)?
Environment: Do(es) the scientific environment(s) in which the work will be done contribute to the probability of success? Do the proposed studies benefit from unique features of the scientific environment, or subject populations, or employ useful collaborative arrangements? Is there evidence of institutional support? Is there evidence that the PD/PI(s) and other key personnel will be able to successfully implement their study in the medical settings proposed?
Additional Review Criteria
In addition to the above criteria, the following items will continue to be considered in the determination of scientific merit and the priority score:
of Human Subjects from Research Risk: The involvement of human
subjects and protections from research risk relating to their participation in
the proposed research will be assessed. See the "Human Subjects Sections"
of the PHS398 Research Plan component of the SF424 (R&R)..
Inclusion of Women, Minorities and Children in Research: The adequacy of plans to include subjects from both genders, all racial and ethnic groups (and subgroups), and children as appropriate for the scientific goals of the research will be assessed. Plans for the recruitment and retention of subjects will also be evaluated. See the "Human Subjects Sections" of the PHS398 Research Plan component of the SF424 (R&R)
Biohazards: If materials or procedures are proposed that are potentially hazardous to research personnel and/or the environment, determine if the proposed protection is adequate.
2.B. Additional Review
Budget and Period of Support: The reasonableness of the proposed budget and the appropriateness of the requested period of support in relation to the proposed research may be assessed by the reviewers. The priority score should not be affected by the evaluation of the budget.
Applications from Foreign Organizations: Whether the project presents special opportunities for furthering research programs through the use of unusual talent, resources, populations, or environmental conditions in other countries that are not readily available in the United States or that augment existing U.S. resources will be assessed.
2.C. Sharing Research Data
Data Sharing Plan: The reasonableness of the data sharing plan or the rationale for not sharing research data may be assessed by the reviewers. However, reviewers will not factor the proposed data sharing plan into the determination of scientific merit or the priority score. The funding organization will be responsible for monitoring the data sharing policy. https://grants.nih.gov/grants/policy/data_sharing.
2.D. Sharing Research Resources
NIH policy requires that grant awardee recipients make unique research resources readily available for research purposes to qualified individuals within the scientific community after publication (See the NIH Grants Policy Statement https://grants.nih.gov/archive/grants/policy/nihgps_2003/index.htm#_Toc54600131). Investigators responding to this funding opportunity should include a sharing research resources plan addressing how unique research resources will be shared or explain why sharing is not possible.
Program staff will be responsible for the administrative review of the plan for sharing research resources.
adequacy of the resources sharing plan and any related data sharing plans will
be considered by Program staff of the funding organization when making
recommendations about funding applications. The effectiveness of the resource
sharing will be evaluated as part of the administrative review of each Non-Competing Grant
Progress Report (PHS 2590), See Section VI.3.,
3. Anticipated Announcement and Award Dates
Not Applicable
Section VI. Award Administration Information
1. Award Notices
After the peer review of the application is completed, the PD/PI will be able to access his or her Summary Statement (written critique) via the NIH eRA Commons.
the application is under consideration for funding, NIH will request
"just-in-time" information from the applicant. For details,
applicants may refer to the NIH
Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards,
Subpart A: General.
A formal notification in the form of a Notice of Award (NoA) will be provided to the applicant organization. The NoA signed by the grants management officer is the authorizing document. Once all administrative and programmatic issues have been resolved, the NoA will be generated via email notification from the awarding component to the grantee business official.
Selection of an application for award is not an authorization to begin performance. Any costs incurred before receipt of the NoA are at the recipient's risk. These costs may be reimbursed only to the extent considered allowable pre-award costs. See Section IV.5., "Funding Restrictions."
2. Administrative and National Policy Requirements
All NIH grant and cooperative agreement awards include the NIH Grants Policy Statement as part of the NoA. For these terms of award, see the NIH Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards, Subpart A: General and Part II: Terms and Conditions of NIH Grant Awards, Subpart B: Terms and Conditions for Specific Types of Grants, Grantees, and Activities.
3. Reporting
When multiple years are involved, awardees will be required to submit the Non-Competing Grant Progress Report (PHS 2590) annually and financial statements as required in the NIH Grants Policy Statement. Annual report submission will be required to NIDA and designated SAMHSA representative.
encourage your inquiries concerning this funding opportunity and welcome the
opportunity to answer questions from potential applicants. Inquiries may fall
into three areas: scientific/research, peer review, and financial or grants
management issues:
1. Scientific/Research Contact(s):
Richard A.
Denisco MD, MPH
National Institute on Drug Abuse, NIH, DHHS
6001 Executive Boulevard
Room 5185
Bethesda, MD 20892
Telephone: (301) 594 4371
2. Peer Review Contact(s):
Levitin, Ph.D.
Office of Extramural Affairs
National Institute on Drug Abuse, NIH, DHHS
6101 Executive Boulevard, Suite 234, MSC 8401
Bethesda, Maryland 20892-8401
Telephone: (301) 443-2755
Email: email@example.com
3. Financial/Grants Management Contact(s):
Edith Davis
Grants Management Specialist
Grants Management Branch
National Institute on Drug Abuse, NIH, DHHS
6101 Executive Boulevard
Suite 270 MSC 8403
Bethesda MD 20892-8403
Telephone: (301) 443-6710
E-mail: email@example.com
Section VIII. Other Information
Required Federal Citations
Human Subjects Protection:
Federal regulations (45 CFR 46) require that applications and proposals involving human subjects must be evaluated with reference to the risks to the subjects, the adequacy of protection against these risks, the potential benefits of the research to the subjects and others, and the importance of the knowledge gained or to be gained (http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm).
Data and Safety Monitoring Plan:
Data and safety monitoring is required for all types of clinical trials, including physiologic toxicity and dose-finding studies (Phase I); efficacy studies (Phase II); efficacy, effectiveness and comparative trials (Phase III). Monitoring should be commensurate with risk. The establishment of data and safety monitoring boards (DSMBs) is required for multi-site clinical trials involving interventions that entail potential risks to the participants ("NIH Policy for Data and Safety Monitoring," NIH Guide for Grants and Contracts, https://grants.nih.gov/grants/guide/notice-files/not98-084.html).
Sharing Research Data:
Investigators submitting an NIH application seeking $500,000 or more in direct costs in any single year are expected to include a plan for data sharing or state why this is not possible (https://grants.nih.gov/grants/policy/data_sharing).
Investigators should seek guidance from their institutions, on issues related to institutional policies and local IRB rules, as well as local, State and Federal laws and regulations, including the Privacy Rule. Reviewers will consider the data sharing plan but will not factor the plan into the determination of the scientific merit or the priority score.
to Research Data through the Freedom of Information Act:
The Office of Management and Budget (OMB) Circular A-110 has been revised to provide access to research data through the Freedom of Information Act (FOIA) under some circumstances. Data that are (1) first produced in a project that is supported in whole or in part with Federal funds and (2) cited publicly and officially by a Federal agency in support of an action that has the force and effect of law (i.e., a regulation) may be accessed through FOIA. It is important for applicants to understand the basic scope of this amendment. NIH has provided guidance at https://grants.nih.gov/grants/policy/a110/a110_guidance_dec1999.htm. Applicants may wish to place data collected under this funding opportunity in a public archive, which can provide protections for the data and manage the distribution for an indefinite period of time. If so, the application should include a description of the archiving plan in the study design and include information about this in the budget justification section of the application. In addition, applicants should think about how to structure informed consent statements and other human subjects procedures given the potential for wider use of data collected under this award.
Sharing of Model Organisms:
NIH is committed to support efforts that encourage sharing of important research resources including the sharing of model organisms for biomedical research (see https://grants.nih.gov/grants/policy/model_organism/index.htm). At the same time the NIH recognizes the rights of grantees and contractors to elect and retain title to subject inventions developed with Federal funding pursuant to the Bayh Dole Act (see the NIH Grants Policy Statement. Beginning October 1, 2004, all investigators submitting an NIH application or contract proposal are expected to include in the application/proposal a description of a specific plan for sharing and distributing unique model organism research resources generated using NIH funding or state why such sharing is restricted or not possible. This will permit other researchers to benefit from the resources developed with public funding. The inclusion of a model organism sharing plan is not subject to a cost threshold in any year and is expected to be included in all applications where the development of model organisms is anticipated.
Inclusion of Women And Minorities in Clinical Research:
It is the policy of the NIH that women and members of minority groups and their sub-populations must be included in all NIH-supported clinical research projects unless a clear and compelling justification is provided indicating that inclusion is inappropriate with respect to the health of the subjects or the purpose of the research. This policy results from the NIH Revitalization Act of 1993 (Section 492B of Public Law 103-43). All investigators proposing clinical research should read the "NIH Guidelines for Inclusion of Women and Minorities as Subjects in Clinical Research" (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-02-001.html); a complete copy of the updated Guidelines is available at https://grants.nih.gov/grants/funding/women_min/guidelines_amended_10_2001.htm. The amended policy incorporates: the use of an NIH definition of clinical research; updated racial and ethnic categories in compliance with the new OMB standards; clarification of language governing NIH-defined Phase III clinical trials consistent with the SF424 (R&R) application; and updated roles and responsibilities of NIH staff and the extramural community. The policy continues to require for all NIH-defined Phase III clinical trials that: a) all applications or proposals and/or protocols must provide a description of plans to conduct analyses, as appropriate, to address differences by sex/gender and/or racial/ethnic groups, including subgroups if applicable; and b) investigators must report annual accrual and progress in conducting analyses, as appropriate, by sex/gender and/or racial/ethnic group differences.
Inclusion of Children as Participants in Clinical Research:
The NIH maintains a policy that children (i.e., individuals under the age of 21) must be included in all clinical research, conducted or supported by the NIH, unless there are scientific and ethical reasons not to include them.
All investigators proposing research involving human subjects should read the "NIH Policy and Guidelines" on the inclusion of children as participants in research involving human subjects (https://grants.nih.gov/grants/funding/children/children.htm).
Required Education on the Protection of Human Subject Participants:
NIH policy requires education on the protection of human subject participants for all investigators submitting NIH applications for research involving human subjects and individuals designated as key personnel. The policy is available at https://grants.nih.gov/grants/guide/notice-files/NOT-OD-00-039.html.
Human Embryonic Stem Cells (hESC):
Criteria for federal funding of research on hESCs can be found at http://stemcells.nih.gov/index.asp and at https://grants.nih.gov/grants/guide/notice-files/NOT-OD-02-005.html. Only research using hESC lines that are registered in the NIH Human Embryonic Stem Cell Registry will be eligible for Federal funding (http://escr.nih.gov/). It is the responsibility of the applicant to provide in the project description and elsewhere in the application as appropriate, the official NIH identifier(s) for the hESC line(s) to be used in the proposed research. Applications that do not provide this information will be returned without review.
NIH Public Access Policy:
NIH-funded investigators are requested to submit to the NIH manuscript submission (NIHMS) system (http://www.nihms.nih.gov/) at PubMed Central (PMC) an electronic version of the author's final manuscript upon acceptance for publication, resulting from research supported in whole or in part with direct costs from NIH. The author's final manuscript is defined as the final version accepted for journal publication, and includes all modifications from the publishing peer review process.
NIH is requesting that authors submit manuscripts resulting from 1) currently funded NIH research projects or 2) previously supported NIH research projects if they are accepted for publication on or after May 2, 2005. The NIH Public Access Policy applies to all research grant and career development award mechanisms, cooperative agreements, contracts, Institutional and Individual Ruth L. Kirschstein National Research Service Awards, as well as NIH intramural research studies. The Policy applies to peer-reviewed, original research publications that have been supported in whole or in part with direct costs from NIH, but it does not apply to book chapters, editorials, reviews, or conference proceedings. Publications resulting from non-NIH-supported research projects should not be submitted.
For more information about the Policy or the submission process, please visit the NIH Public Access Policy Web site at http://publicaccess.nih.gov// and view the Policy or other Resources and Tools, including the Authors' Manual.
Standards for Privacy of Individually Identifiable Health Information:
The Department of Health and Human Services (HHS) issued final modification to the "Standards for Privacy of Individually Identifiable Health Information", the "Privacy Rule", on August 14, 2002. The Privacy Rule is a federal regulation under the Health Insurance Portability and Accountability Act (HIPAA) of 1996 that governs the protection of individually identifiable health information, and is administered and enforced by the HHS Office for Civil Rights (OCR).
Decisions about applicability and implementation of the Privacy Rule reside with the researcher and his/her institution. The OCR website (http://www.hhs.gov/ocr/) provides information on the Privacy Rule, including a complete Regulation Text and a set of decision tools on "Am I a covered entity?" Information on the impact of the HIPAA Privacy Rule on NIH processes involving the review, funding, and progress monitoring of grants, cooperative agreements, and research contracts can be found at https://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-025.html.
URLs in NIH Grant Applications or Appendices:
All applications and proposals for NIH funding must be self-contained within specified page limitations. For publications listed in the appendix and/or Progress report, internet addresses (URLs) must be used for publicly accessible on-line journal articles. Unless otherwise specified in this solicitation, Internet addresses (URLs) should not be used to provide any other information necessary for the review because reviewers are under no obligation to view the Internet sites. Furthermore, we caution reviewers that their anonymity may be compromised when they directly access an Internet site.
People 2010:
The Public Health Service (PHS) is committed to achieving the health promotion and disease prevention objectives of "Healthy People 2010," a PHS-led national activity for setting priority areas. This PA is related to one or more of the priority areas. Potential applicants may obtain a copy of "Healthy People 2010" at http://www.health.gov/healthypeople.
Authority and Regulations:
This program is described in the Catalog of Federal Domestic Assistance at http://www.cfda.gov/ and is not subject to the intergovernmental review requirements of Executive Order 12372 or Health Systems Agency review. Awards are made under the authorization of Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 45 CFR Parts 74 and 92. All awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.
The PHS strongly encourages all grant recipients to provide a smoke-free workplace and discourage the use of all tobacco products. In addition, Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking in certain facilities (or in some cases, any portion of a facility) in which regular or routine education, library, day care, health care, or early childhood development services are provided to children. This is consistent with the PHS mission to protect and advance the physical and mental health of the American people.
Loan Repayment Programs:
NIH encourages applications for educational loan repayment from qualified health professionals who have made a commitment to pursue a research career involving clinical, pediatric, contraception, infertility, and health disparities related areas. The LRP is an important component of NIH's efforts to recruit and retain the next generation of researchers by providing the means for developing a research career unfettered by the burden of student loan debt. Note that an NIH grant is not required for eligibility and concurrent career award and LRP applications are encouraged. The periods of career award and LRP award may overlap providing the LRP recipient with the required commitment of time and effort, as LRP awardees must commit at least 50% of their time (at least 20 hours per week based on a 40 hour week) for two years to the research. For further information, please see: http://www.lrp.nih.gov/.
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
Research (OER)
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.


text:
Hudson -- An umbrella mistaken for a rifle led to a 20-minute lock down at Hudson High School Wednesday morning.
School officials ordered all doors locked at the high school around 7:30 a.m. after a teacher reported seeing an unidentified person in the parking lot holding what appeared to be a rifle and wearing a hunting cap.
It turned out the person, an employee of Hudson Cable TV, was carrying an umbrella.
Superintendent Steve Farnsworth sent out telephone alert to parents advising them of the situation.
"Responding quickly and appropriately by using the recommended 'see something, say something' procedure, the building was locked down and the police were called," the alert said.
The incident was resolved in about 20 minutes, Farnsworth said.


text:
Exercise After Breast Cancer
Dear OncoLink "Ask The Experts,"
Although my wife and I have been told that squash and tennis (which my wife played before her mastectomy) is not recommended, I am curious to know why? Whereas weight training seems to be getting a cautious 'green light', are there specific reasons why racket sports and the type of arm movement involved would definitely be a 'red light' for arm lymphedema sufferers?
Linda McGrath Boyle PT, DPT CLT-LANA, Cancer Rehab Specialist and OncoLink Lymphedema Team Editor, responds:
The issue here appears to be one of gradually increasing activity. If you weight lift or run or play racquet sports, there needs to be a gradual increase in exercise duration and intensity. Before breast cancer, it was fine to be a weekend warrior; you would be sore and then heal. The problem is that your lymphatic system in the axilla (armpit)/chest wall/ clavicular (collar bone) areas no longer works at 100%. Therefore, you must monitor your body's response to increased blood flow, which in turn can increase you lymphatic flow tenfold. If your lymph nodes in the affected area cannot handle this sudden increase in lymphatic volume, you run the risk of swelling due to sudden lymphatic overload.
Everyone's lymphatic system has a maximum transport capacity that prevents swelling. This is inherited, meaning it is set at birth. This transport capacity is reduced following surgery and radiation.
Rules of engagement
- Warm up gradually, for 10 minutes before working out.
- Cool down for 10 minutes after exercising.
- VERY gradually increase duration (time) and intensity (effort) of exercise. This increase in activity must be at a rate that is MUCH more gradual than before breast cancer. Monitor arm girth and symptoms of lymphedema onset (numbness, tingling, heaviness, achiness, fullness, swelling). If you develop symptoms, you need to decrease your activity duration and intensity.
- Exercise regularly. Sudden sporadic increases in lymphatic activity may lead to swelling.
If your doctor is in agreement...
Racquet sports are very demanding due to high repetition, high velocity muscle contractions. You would do well to stretch your neck, shoulder and entire arm/wrist/hand, as well as gradually strengthen your core muscles and upper body/arms in preparation for participating in racquet sports.
Do not discontinue strengthening/stretching once you add racquet sports, or you will lose flexibility and strength. This could lead to injury. Proper form is very important if you are to play racquet sports.
Warm up with a walk for 10 minutes. Do not play cold. Begin with 5 minutes at 25% effort and monitor your body's response. Very gradually increase your activity if you do not become symptomatic. Cool down for 10 minutes after playing.
If you injure your arm or chest wall on the breast cancer side, your body will swell in response. Because your lymphatic system is compromised, it may be difficult for it to handle the sudden increase in volume that is normal in response to an injury. This injury could trigger lymphedema.
The best thing to do is discuss with your physician/ nurse practitioner and consult a person who specializes in the treatment of lymphedema (CLT-LANA--certified lymphedema therapist who has passed the Lymphology Association of North America's national certification examination).


text:
The other day while reading and praying from my Bible, I came across Psalm 137. I thought for a moment about just how direct God's word can be.
God is God, and as the creator of all that is, he has the right to be as direct as he needs to be in his word choice in Sacred Scripture.
Oddly our society today doesn't seem to appreciate directness. Society seems to have developed an evolving flair for diluting or minimizing moral authority and substituting it with language which is politically correct, laundered so meaning is often blurred or obscured.
Let's look at the Psalm again: "Lord let my tongue be silenced if I ever forget you."
Out of what experience was that coming, and I wonder what I might learn from it? Here we find the children of Israel again in physical captivity, forcibly taken to what is now modern day Iraq to serve as slaves to the Babylonians. They long for the freedoms they took for granted in their beloved Jerusalem, which had been destroyed. Still they had hope and faith because they held firm to the covenant between them and God from long ago.
Hope and faith are both gifts from God; things that can never be taken from us. However they require exercise and nurturing on a regular basis in order to be sustained and to grow.
The Psalm goes on to have the captors of the Jewish people request joyful songs that lament the loss felt by those so far from home. With courage they continue to sing, "If I forget you Jerusalem, may my right hand be forgotten." The reflection of faith, hope and trust in God's providence is an expression of the true bond desired between God and his creation.
Is such faith warranted? Does the Psalmist really stick his neck out that far, or are these just words? In the Psalm we have a person poetically and melodiously highlighting an ideal state of faith and love between man and God, which seems unattainable for most to ever desire, much less achieve. The joy comes from faith, for in the eyes of those, who live and believe in Christ crucified and raised, there is the proven belief is God's love manifested through the donation of his Son for the salvation of all humanity. In the Son, we touch, see and learn from him who offered his very life and suffering upon the Cross and has never forgotten us, and never will.
Words do mean something. There is a higher moral authority that speaks and teaches and witnesses in real and profound ways the love and respect He holds for his creation, and the manner in which our faith response calls us to approach not only the Trinity, but also our fellow man.
For all those on their Lenten journeys, blessed trip, may you always strive to recognize Christ in those you meet and may your life be a teaching instrument for those whose faith is lacking.
Father Joe Smith is Pastor at St. Anne Catholic Church in Richmond Hill. He can be reached at firstname.lastname@example.com.


text:
DoSomething is creating a home for Australian community volunteering.
Watch our informative TV ad from Sandra Sully!
Contact Details
- Phone:
- Show number
Incorrect info? Claim or edit this listing
Mudgeeraba Little Athletics Centre
Little Athletics Australia promotes family, fun and fitness. Both children and volunteers are encouraged to achieve their personal best. Little Athletics understands the importance of developing physical fitness at an early age for children of all abilities. Children are encouraged to have fun while enjoying their sport within a friendly and interactive environment.
Getting Involved
If your child is interested in participating in Little Athletics, simply register with your local Little Athletics Centre. Please contact your local centre for further details on registering in-person or online. Children with any level of skill or fitness are encouraged to join.
Little Athletics is a voluntary organisation. Many centres would not be able to operate without the ongoing support of their volunteers. Getting involved with Little Athletics could include officiating an event, managing an age group, recording results, or working in the canteen.
All parents are encouraged to becoming involved with their child's sporting program. Little Athletics is one of the few sports where parents can become fully involved in their child's sporting interests.
More Information: http://www.littleathletics.com.au/


text:
April 13, 2016, 12:40 pm
The guys take a crack at the playoff series that have been squared away as of Tuesday night, talk about sending Chris Rock, Amy Schumer and Borat to negotiate with ISIS and also have extended Clippers/Blazers discussion.
Podcast: Play in new window | Download
Subscribe: iTunes | Android | RSS | More Subscribe Options
Fantasy News
August 22, 2019, 8:23 pmRobert CovingtonSF, Minnesota Timberwolves
Robert Covington (right knee bone bruise) will reportedly be "good to go" for the start of training camp in October.
Well, this is good news that we didn't hope we would need. Covington played 35 games last year and couldn't get over the bone bruise injury that kept him out for a majority of the year. We expected him to be ready to go, and the fact that we're even discussing this is slightly less than ideal.
Source: Dane Moore on Twitter
August 22, 2019, 3:27 pmKemba WalkerPG, Boston Celtics
Team USA has named Kemba Walker, Marcus Smart and Donovan Mitchell as captains for the FIBA World Cup.
Congratulations to Mitchell, Walker and Smart on the tremendous honor of being named captains for the USA men's team. This won't have any impact on their upcoming fantasy seasons, but it is a major accomplishment nonetheless. Team USA has an exhibition rematch against Team Australia on Saturday.
August 22, 2019, 12:25 pmIsaiah CanaanPG, International
Isaiah Canaan has signed a contract with the Shangdong Heroes of the Chinese Basketball Association.
The veteran journeyman played for the Suns, Wolves and Bucks last season, appearing in 30 games total. Canaan will be looking at a more prominent role and payday overseas as he attempts to build his value back up before trying to latch on to a team towards the end of the year. Canaan is off the fantasy radar.
Source: Zhang Duo on Twitter
August 22, 2019, 11:58 amPatty MillsPG, San Antonio Spurs
Patty Mills put up 19 points, three assists, two steals, a block and three 3-pointers in Thursday's international exhibition between Team Australia and Team USA.
The Boomers figure to be one of the chief threats to the Americans in the World Cup and put forth a competitive effort in today's exhibition. Mills has typically been a steady, late-round fantasy option for deep-league play but that may change this season as the Spurs will need to mix in both Derrick White and Dejounte Murray in the backcourt. Chris Goulding tied for the team lead in points, also scoring 19 while hitting four 3-pointers in 22 minutes off the bench.
August 22, 2019, 11:54 amMyles TurnerC, Indiana Pacers
Myles Turner put up 15 points and 14 rebounds in Thursday's exhibition win over Team Australia, shooting 6-of-8 from the floor with a 3-pointer.
Turner didn't get any blocks but we know that last year's league-leader can rack those up in a hurry, whether he's getting them in international competition or not. Look for another early-middle round season out of the talented big man. Kemba Walker led Team USA with 23 points in the 102-86 win.
August 21, 2019, 6:26 pmTrevon BluiettPF, Utah Jazz
Trevon Bluiett and Juwan Morgan sign with the Jazz in the hopes of one day playing in an NBA game.
Bluiett was on a two-way contract with the Pelicans last season while Juwan Morgan played for the Jazz in the 2019 Summer League. They will both compete for a roster spot in training camp but neither is a guarantee to make the final roster. They both have yet to see the court in an NBA game and can be ignored from a fantasy perspective until that day comes.
Source: Tony Jones on Twitter
August 21, 2019, 5:25 pmZach CollinsC, Portland Trail Blazers
Zach Collins (ankle) began daily contact workouts on Monday and is on pace to head into training camp fully healthy.
Collins is heading into what could be a breakout season as he is likely to start at the power forward position. In the 2019 playoffs, the Gonzaga product blocked a shot in 11 of the 16 games including three games in which he blocked three, four and five respectively. Collins has averaged around 33% from distance throughout his career which is exactly what he shot in the postseason (7-21). If he is able to improve from long range and plays starters minutes, Collins is a can't-miss player. It's far from a guarantee though as the 21-year-old has never finished with standard-league value. It does seem like Collins will be ready for training camp barring a major setback.
Source: The Athletic
August 21, 2019, 10:34 amCory JosephPG, Sacramento Kings
Nick Nurse said that reports of Cory Joseph missing the FIBA World Cup are "incorrect".
Nurse added that he spoke to Joseph on Wednesday and that the guard has his flights booked to China. Joseph was in Canada's camp at home earlier this month, but did not make the trip to Australia and has missed the past four exhibition games. The situation has become a little bit murky but Canada Basketball keeps holding out hope that Joseph will rejoin the team before they depart for China, which doesn't happen until Monday.
Source: John Casey on Twitter
August 20, 2019, 10:33 pmTyronn LuePG, Los Angeles Clippers
Shams Charania of The Athletic is reporting former Cavs championship-winning coach Tyronn Lue has agreed to join the Clippers as their top assistant coach to Doc Rivers.
The Lakers and Clippers rivalry continues to heat up. Lue was very close to a deal with the Lakers in May to become their head coach, but the sides couldn't reach an agreement. Lue now joins Kawhi Leonard as another person to spurn the Lakers this offseason.
Source: Shams Charania on Twitter
August 20, 2019, 10:28 pmPJ TuckerSF, Houston Rockets
P.J. Tucker says he is optimistic about signing a contract extension soon.
The 34-year-old 3-and-D wing hopes to extend his deal with the Rockets, but a potential extension wouldn't begin until his age-36 season. Houston has him under contract for two more seasons at this point, so they may not be motivated enough to get something done this offseason. However, a maximum Tucker extension would only have him in the $10 million per year range. Even as a 37-year-old, that could be a great deal if he can keep up his current production. Tucker remains a sneaky source of threes and steals late in fantasy drafts or off the wire.
Source: Kurt Helin on Twitter


text:
It's quite strange for me to write here. I have to get my head out of blogging for work. This does not have to be about digital democracy or civic engagement.
It can be, if you want it to be.
But maybe we'd both rather it wasn't.
So Life. I am barely here because my job is internet based and sometimes I feel like I...
Read More
VIEW 5 of 5 COMMENTS
Sorry to hear about the house stress. I've been going through something similar although on the selling. Why does everything move at such a slow pace and so uncertain? Hope it works for you guys.